WO2004076614A3 - Human nucleic acid sequences obtained from prostatic carcinomas - Google Patents

Human nucleic acid sequences obtained from prostatic carcinomas Download PDF

Info

Publication number
WO2004076614A3
WO2004076614A3 PCT/DE2004/000433 DE2004000433W WO2004076614A3 WO 2004076614 A3 WO2004076614 A3 WO 2004076614A3 DE 2004000433 W DE2004000433 W DE 2004000433W WO 2004076614 A3 WO2004076614 A3 WO 2004076614A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
sequences obtained
human nucleic
prostatic carcinomas
Prior art date
Application number
PCT/DE2004/000433
Other languages
German (de)
French (fr)
Other versions
WO2004076614A2 (en
Inventor
Bernd Hinzmann
Edgar Dahl
Andre Rosenthal
Thomas Specht
Armin Schmitt
Georg Beckmann
Thomas Bruemmendorf
Henrik Kinnemann
Stefan Roepcke
Klaus Hermann
Li Xinzhong
Christian Pilarsky
Eike Staub
Original Assignee
Bernd Hinzmann
Edgar Dahl
Andre Rosenthal
Thomas Specht
Armin Schmitt
Georg Beckmann
Thomas Bruemmendorf
Henrik Kinnemann
Stefan Roepcke
Klaus Hermann
Li Xinzhong
Christian Pilarsky
Eike Staub
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10309985A external-priority patent/DE10309985A1/en
Priority claimed from DE2003122134 external-priority patent/DE10322134A1/en
Application filed by Bernd Hinzmann, Edgar Dahl, Andre Rosenthal, Thomas Specht, Armin Schmitt, Georg Beckmann, Thomas Bruemmendorf, Henrik Kinnemann, Stefan Roepcke, Klaus Hermann, Li Xinzhong, Christian Pilarsky, Eike Staub filed Critical Bernd Hinzmann
Publication of WO2004076614A2 publication Critical patent/WO2004076614A2/en
Publication of WO2004076614A3 publication Critical patent/WO2004076614A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to novel human nucleic acid sequences obtained from prostatic carcinomas, to proteins and peptides coded by said sequences and to the use of the latter for the diagnosis and/or treatment of prostatic cancer.
PCT/DE2004/000433 2003-02-27 2004-02-22 Human nucleic acid sequences obtained from prostatic carcinomas WO2004076614A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10309985.9 2003-02-27
DE10309985A DE10309985A1 (en) 2003-02-27 2003-02-27 New nucleic acids, and encoded proteins, from prostatic cancer tissue, useful for diagnosis, treatment and in screening for specific binding agents
DE2003122134 DE10322134A1 (en) 2003-05-14 2003-05-14 New nucleic acids, and encoded proteins, from prostatic cancer tissue, useful for diagnosis, treatment and in screening for specific binding agents
DE10322134.4 2003-05-14

Publications (2)

Publication Number Publication Date
WO2004076614A2 WO2004076614A2 (en) 2004-09-10
WO2004076614A3 true WO2004076614A3 (en) 2005-08-18

Family

ID=32928861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2004/000433 WO2004076614A2 (en) 2003-02-27 2004-02-22 Human nucleic acid sequences obtained from prostatic carcinomas

Country Status (1)

Country Link
WO (1) WO2004076614A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
WO2005103712A2 (en) * 2004-04-20 2005-11-03 Sphingotec Gmbh Use of precursors of tachykinins and/or their fragments in medical diagnostic
CA2992180C (en) 2004-05-07 2021-02-23 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
US7531624B2 (en) 2004-12-03 2009-05-12 Medtrain Technologies, Llc Nuclear targeting sequence
EP1851543A2 (en) 2005-02-24 2007-11-07 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
GB0526498D0 (en) * 2005-12-28 2006-02-08 Randox Lab Ltd Method
US20070237713A1 (en) 2006-04-04 2007-10-11 Fan Rong A PCan065 Antibody Compositions and Methods of Use
CA2697970A1 (en) * 2007-08-30 2009-03-05 Santaris Pharma A/S Rna antagonist compounds for the modulation of fabp4/ap2
CN101842113B (en) * 2007-10-25 2015-06-17 东丽株式会社 Immune response inducer
MA34527B1 (en) 2010-08-27 2013-09-02 Gilead Biologics Inc ANTIBODIES AGAINST METALLOPROTEINASE OF MATRIX 9
EA201491599A1 (en) 2012-02-29 2015-05-29 Джилид Байолоджикс, Инк. ANTIBODIES TO MATRIX METALLOPROTEINASE 9
ES2720763T3 (en) * 2012-06-27 2019-07-24 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
JP6759229B2 (en) 2014-12-08 2020-09-23 バーグ エルエルシー Use of markers containing filamin A in the diagnosis and treatment of prostate cancer
IT201600127428A1 (en) 2016-12-16 2018-06-16 Cusani Alberto Bartorelli NEW RECOMBINANT UK 114 PROTEIN IN STABLE POLYMER FORM FOR USE IN THERAPY, IN DIAGNOSTICS AND IN THE PREVENTION OF MALIGNE NEOPLASIA

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029245A2 (en) * 1994-04-25 1995-11-02 Association Pour Le Developpement De La Recherche En Genetique Moleculaire (A De Re Ge M) Btf2 complex proteins and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029245A2 (en) * 1994-04-25 1995-11-02 Association Pour Le Developpement De La Recherche En Genetique Moleculaire (A De Re Ge M) Btf2 complex proteins and uses thereof

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BONKHOFF H ET AL: "DIFFERENTIAL EXPRESSION OF THE PS2 PROTEIN IN THE HUMAN PROSTATE AND PROSTATE CANCER: ASSOCIATION WITH PREMALIGNANT CHANGES AND NEUROENDOCRINE DIFFERENTIATION", HUMAN PATHOLOGY, SAUNDERS, PHILADELPHIA, PA, US, vol. 26, no. 8, August 1995 (1995-08-01), pages 824 - 828, XP009010130, ISSN: 0046-8177 *
DATABASE EMBL [online] 16 November 2001 (2001-11-16), "TFIIH basal transcription factor complex p44 subunit(BTF2-p44)", XP002304612, retrieved from EBI accession no. Q13888 Database accession no. Q13888 *
DATABASE EMBL [online] 6 June 1996 (1996-06-06), EGLY: "Transcription factor BTF2 complex p44 subunit", XP002304611, retrieved from EBI accession no. AAR88225 Database accession no. AAR88225 *
FIGUEROA J A ET AL: "DIFFERENTIAL EXPRESSION OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS IN HIGH VERSUS LOW GLEASON SCORE PROSTATE CANCER", JOURNAL OF UROLOGY, BALTIMORE, MD, US, vol. 159, no. 4, April 1998 (1998-04-01), pages 1379 - 1383, XP000971791, ISSN: 0022-5347 *
HUMBERT S ET AL: "P44 AND P34 SUBUNITS OF THE BTF2/TFIIH TRANSCRIPTION FACTOR HAVE HOMOLOGIES WITH SSL1 A YEAST PROTEIN INVOLVED IN DNA REPAIR", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 13, no. 10, 1994, pages 2393 - 2398, XP002047712, ISSN: 0261-4189 *
LEE DONG KUN ET AL: "Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 13, 30 March 2001 (2001-03-30), pages 9978 - 9984, XP002304609, ISSN: 0021-9258 *
LEE DONG KUN ET AL: "From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH2-terminal associated coactivator", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 13, 31 March 2000 (2000-03-31), pages 9308 - 9313, XP002304610, ISSN: 0021-9258 *
NG A Y K ET AL: "DIFFERENTIAL EXPRESSION OF HSIM2 IN PROSTATE CANCER", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 40, March 1999 (1999-03-01), pages 232, XP000986062, ISSN: 0197-016X *
THOMAS R ET AL: "Differential expression of placental bone morphogenetic protein (PLAB) gene during prostate cancer progression to bone", PROCEEDINGS OF THE 91ST ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. SAN FRANCISCO, CA, APRIL 1 - 5, 2000, PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, PHILADELPHIA, PA : AACR, US, vol. VOL. 41, 1 April 2000 (2000-04-01), pages 587, XP002180666 *

Also Published As

Publication number Publication date
WO2004076614A2 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
EP1440981A3 (en) Full-length human cdna
WO1999053040A3 (en) Human nucleic acid sequences from ovarian tumour tissue
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2004076614A3 (en) Human nucleic acid sequences obtained from prostatic carcinomas
WO2005019264A3 (en) Human lxr alpha variants
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2004015060A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001081578A3 (en) Novel proteins and nucleic acids encoding same
WO1999046374A3 (en) Human nucleic acid sequences from prostate tumour tissue
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2003102185A3 (en) Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO2002000691A3 (en) Polynucleotides and polypeptides encoded thereby
WO2002079398A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002099116A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004076613A3 (en) Human nucleic acid sequences from carcinomas of the bladder
WO2002083841A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2002070559A3 (en) Nuclear hormone receptor ligand binding domains
WO2004056983A3 (en) Metalloprotease proteins
WO2001051518A3 (en) Nucleic acids encoding human semaphorin proteins and use thereof
WO2002062845A3 (en) Adhesion molecules
WO2002033058A3 (en) Novel cysteine proteases and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: MITTEILUNG EINES RECHTSVERLUSTES NACH REGEL 69(1), VOM 25.11.2005 (EPO FORM 1205A)

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: FESTSTELLUNG EINES RECHTSVERLUSTES NACH REGEL 69(1) EPUE. (EPO FORM 1205A VOM 25.11.2005)

122 Ep: pct application non-entry in european phase